314 related articles for article (PubMed ID: 28882698)
61. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
62. Comparing MicroRNA Profilings of Purified HER-2-Negative and HER-2-Positive Cells Validates miR-362-5p/Sema3A as Characteristic Molecular Change in Triple-Negative Breast Cancers.
Zhang X; He Q; Sun L; Zhang Y; Qin S; Fan J; Wang J
Dis Markers; 2019; 2019():6057280. PubMed ID: 31929841
[TBL] [Abstract][Full Text] [Related]
63. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
64. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
[TBL] [Abstract][Full Text] [Related]
65. Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer.
Bajaj R; Tripathi R; Sridhar TS; Korlimarla A; Choudhury KD; Suryavanshi M; Mehta A; Doval DC
PLoS One; 2020; 15(11):e0242190. PubMed ID: 33175907
[TBL] [Abstract][Full Text] [Related]
66. miRNA-200c and miRNA-141 as potential prognostic biomarkers and regulators of epithelial-mesenchymal transition in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Sharma A; Pushker N; Kashyap S; Bakhshi S; Bajaj MS
Br J Ophthalmol; 2017 Apr; 101(4):536-542. PubMed ID: 28119291
[TBL] [Abstract][Full Text] [Related]
67. Potential Oncogenic Role and Prognostic Implication of MicroRNA-155-5p in Oral Squamous Cell Carcinoma.
Kim H; Yang JM; Ahn SH; Jeong WJ; Chung JH; Paik JH
Anticancer Res; 2018 Sep; 38(9):5193-5200. PubMed ID: 30194167
[TBL] [Abstract][Full Text] [Related]
68. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.
Zaravinos A; Radojicic J; Lambrou GI; Volanis D; Delakas D; Stathopoulos EN; Spandidos DA
J Urol; 2012 Aug; 188(2):615-23. PubMed ID: 22704449
[TBL] [Abstract][Full Text] [Related]
69. MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer.
Han SH; Kim HJ; Gwak JM; Kim M; Chung YR; Park SY
J Breast Cancer; 2017 Mar; 20(1):35-44. PubMed ID: 28382093
[TBL] [Abstract][Full Text] [Related]
70. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
[TBL] [Abstract][Full Text] [Related]
71. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
72. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-493 is a prognostic factor in triple-negative breast cancer.
Yao L; Liu Y; Cao Z; Li J; Huang Y; Hu X; Shao Z
Cancer Sci; 2018 Jul; 109(7):2294-2301. PubMed ID: 29777630
[TBL] [Abstract][Full Text] [Related]
74. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
[TBL] [Abstract][Full Text] [Related]
75. Elevated miR-301a expression indicates a poor prognosis for breast cancer patients.
Zheng JZ; Huang YN; Yao L; Liu YR; Liu S; Hu X; Liu ZB; Shao ZM
Sci Rep; 2018 Feb; 8(1):2225. PubMed ID: 29396508
[TBL] [Abstract][Full Text] [Related]
76. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
77. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
78. Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression.
Rogers TJ; Christenson JL; Greene LI; O'Neill KI; Williams MM; Gordon MA; Nemkov T; D'Alessandro A; Degala GD; Shin J; Tan AC; Cittelly DM; Lambert JR; Richer JK
Mol Cancer Res; 2019 Jan; 17(1):30-41. PubMed ID: 30213797
[TBL] [Abstract][Full Text] [Related]
79. miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.
Fkih M'hamed I; Privat M; Trimeche M; Penault-Llorca F; Bignon YJ; Kenani A
Pathol Oncol Res; 2017 Oct; 23(4):815-827. PubMed ID: 28101798
[TBL] [Abstract][Full Text] [Related]
80. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
